Epilepsy, a chronic neurological disorder, is characterized by recurrent seizures affecting approximately 50 million people globally. Despite the progress in therapeutic strategies, about one-third of patients continue to experience uncontrolled seizures. This article aims to shed light on the recent advancements in epilepsy management, offering a comprehensive update for healthcare professionals.
Newer AEDs offer improved safety profiles, fewer drug interactions, and better tolerability. Drugs such as Brivaracetam, Perampanel, and Lacosamide have shown promising results in controlling both focal and generalized seizures. These drugs work by modulating synaptic transmission, thereby reducing the frequency and severity of seizures.
Neuromodulation therapies such as Vagus Nerve Stimulation (VNS), Deep Brain Stimulation (DBS), and Responsive Neurostimulation (RNS) have emerged as effective treatment options for drug-resistant epilepsy. These therapies work by altering neuronal activity, thereby reducing seizure frequency. RNS, in particular, has shown potential in detecting abnormal electrical activity and delivering corrective stimulation.
Genetic testing has greatly improved our understanding of epilepsy's etiology, leading to the development of precision medicine. Identifying specific genetic mutations allows for targeted therapy, improving treatment outcomes. For instance, Stiripentol has been approved for Dravet syndrome, a severe form of epilepsy caused by SCN1A mutations.
The COVID-19 pandemic has accelerated the adoption of telemedicine in epilepsy care. Telemedicine allows for remote patient monitoring, improving treatment adherence and seizure control. Additionally, digital tools such as seizure detection apps and wearable devices provide real-time data, facilitating personalized care.
In conclusion, the field of epilepsy management has seen significant advancements. The introduction of new AEDs, neuromodulation therapies, precision medicine, and digital tools have improved patient outcomes. As healthcare professionals, staying updated with these advancements is crucial to provide optimal care for patients with epilepsy.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation